Loading...
XNASISRG
Market cap207bUSD
Feb 07, Last price  
591.00USD
1D
-0.94%
1Q
8.67%
Jan 2017
727.39%
Name

Intuitive Surgical Inc

Chart & Performance

D1W1MN
XNAS:ISRG chart
P/E
117.23
P/S
29.59
EPS
5.04
Div Yield, %
Shrs. gr., 5y
0.06%
Rev. gr., 5y
13.85%
Revenues
7.12b
+14.49%
138,803,000227,338,000372,682,000600,828,000874,919,0001,052,168,0001,413,000,0001,757,300,0002,178,800,0002,265,100,0002,131,700,0002,384,400,0002,704,400,0003,128,900,0003,724,200,0004,478,500,0004,358,400,0005,710,100,0006,222,200,0007,124,100,000
Net income
1.80b
+35.98%
23,478,00094,134,00072,044,000144,537,000204,315,000232,606,000381,800,000495,100,000656,600,000671,000,000418,800,000588,800,000735,900,000660,000,0001,127,900,0001,379,300,0001,060,600,0001,704,600,0001,322,300,0001,798,000,000
CFO
1.81b
+21.67%
30,315,00070,787,00099,845,000205,687,000278,235,000385,055,000528,000,000677,600,000814,200,000880,000,000665,100,000771,900,0001,042,900,0001,143,900,0001,169,600,0001,598,200,0001,484,800,0002,089,400,0001,490,800,0001,813,800,000
Earnings
Apr 16, 2025

Profile

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
IPO date
Jun 13, 2000
Employees
12,120
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
7,124,100
14.49%
6,222,200
8.97%
Cost of revenue
3,393,400
2,905,200
Unusual Expense (Income)
NOPBT
3,730,700
3,317,000
NOPBT Margin
52.37%
53.31%
Operating Taxes
141,600
262,400
Tax Rate
3.80%
7.91%
NOPAT
3,589,100
3,054,600
Net income
1,798,000
35.98%
1,322,300
-22.43%
Dividends
Dividend yield
Proceeds from repurchase of equity
(120,000)
(2,373,600)
BB yield
0.10%
2.47%
Debt
Debt current
24,200
Long-term debt
129,000
139,200
Deferred revenue
45,600
41,000
Other long-term liabilities
275,400
398,300
Net debt
(7,214,200)
(9,201,700)
Cash flow
Cash from operating activities
1,813,800
1,490,800
CAPEX
(1,064,200)
(532,400)
Cash from investing activities
(360,100)
1,370,800
Cash from financing activities
(287,600)
(2,572,300)
FCF
1,470,600
2,452,200
Balance
Cash
5,223,200
6,741,500
Long term investments
2,120,000
2,623,600
Excess cash
6,986,995
9,053,990
Stockholders' equity
4,820,900
3,408,700
Invested Capital
8,961,900
7,701,600
ROIC
43.08%
41.19%
ROCE
27.07%
30.04%
EV
Common stock shares outstanding
357,400
362,000
Price
337.36
27.14%
265.35
-26.15%
Market cap
120,572,464
25.52%
96,056,700
-26.92%
EV
113,447,964
86,925,700
EBITDA
4,152,500
3,682,800
EV/EBITDA
27.32
23.60
Interest
29,700
Interest/NOPBT
0.90%